Apheresis Market worth USD 4773.4 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Apheresis Market by Product (Devices and Disposable), by Apheresis Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Other Apheresis Procedures), by Technology (Centrifugation and Membrane Separation), by Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Applications), by Region – Global Share and Forecast to 2030". The global apheresis market size is expected to grow from USD 2,413.3 million in 2021 to USD 4773.4 million by 2030, at a CAGR of 8.9% during the forecast period. The therapeutic Apheresis technique has made great strides in the last few decades. The fourth iteration and the seventh edition of American Society for Apheresis guidelines for therapeutic apheresis have listed 87 diseases with 179 therapeutic apheresis indications, including 14 new diseases and two new indications for previously listed diseases. Owing to the range of indications and therapeutic apheresis procedures, governments of various nations are trying to make this technique accessible to everyone. In the past few decades, this apheresis procedure was included under various reimbursement policies both by government and private insurance firms to market access to each individual. As per Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, 2010 that the therapeutic apheresis procedure indicated for the following indication mentioned the policy of Health Net of California that plasmapheresis, plasma exchange, and therapeutic apheresis are covered under the medical coverage in the United Kingdom.

Global Apheresis Market Segmentation

The overall apheresis market has been segmented into the product,  apheresis procedure, technology, application, and region.

• By Product (Devices and Disposable)
• By Apheresis Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Other Apheresis Procedures)
• By Technology (Centrifugation and Membrane Separation)
• By Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Applications)
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Plasmapheresis, by apheresis procedure, is estimated to hold the largest market share during the forecast period

Based on the apheresis procedure, the global apheresis market is segmented into leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, and other apheresis procedures. The plasmapheresis had the largest market share in 2021. Plasmapheresis is the procedure that involves the removal of harmful antibodies from blood plasma. This process is similar to that of dialysis. However, it is specific to plasma separation. Plasmapheresis plays a vital role in transplant procedures, as it reduces the complications associated with harmful antibodies. The presence of harmful antibodies can lead to rejection of donor blood type during a transplant and kidney transplant failure.

In recent years, plasmapheresis usage has been increasing. It is used to treat critically ill people with infections and other problems, such as Wilson’s disease and thrombotic thrombocytopenic purpura. Hence, the plasmapheresis segment is expected to observe growth in the studied period. In recent years, plasmapheresis usage has been gradually increasing and is used to treat people who are critically ill with infections and other problems, such as thrombotic thrombocytopenic purpura and hence, the plasmapheresis segment is expected to observe a growth in the studied period.

Don't miss out on business opportunities in Apheresis Market. Speak to our research analyst and gain crucial market insights to grow your business.

North America accounts for the largest market share in the apheresis market in 2021

Based on the regions, the global apheresis market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 41.2% in the global apheresis market and was anticipated to maintain its dominance throughout the forecast period. In North America, the US had the largest market share. In recent years, plasmapheresis usage is gradually increasing. It is used to treat critically ill people with infections and other problems, such as Wilson’s disease and thrombotic thrombocytopenic purpura. Hence, the plasmapheresis segment is expected to observe growth in the studied period.

The American Society for Apheresis (ASFA) also aims to advance apheresis medicine for patients, donors, and practitioners through education, evidence-based practice, research, and advocacy. Therefore, the increasing awareness about apheresis treatment is another factor contributing to the growth of this market. Additionally, the increasing cases of COVID-19 have positively impacted the market studied, as the apheresis technique is being widely used to treat COVID-19 as a plasma therapy. Recently in April 2020, Terumo BCT Inc. and Marker Therapeutics AGhas announced that the US Food and Drug Administration (FDA) had issued an Emergency Use Authorization (EUA) for the use of Terumo BCT’s Spectra Optia Apheresis System, combined with Marker Therapeutics’ D2000 Adsorption Cartridge, to treat patients of 18 years age or older with confirmed COVID-19.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the apheresis market. It also consists of the profiles of leading companies such as Haemonetics Corporation, HemaCare Corporation, Fresenius Kabi, Asahi Kasei Medical Co., Ltd, Terumo BCT, Inc., Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, Kaneka Corporation, and Nikkiso Co., Ltd. These market players have focused on acquisitions and expansion to gain a larger market share in the apheresis market.

Browse complete report: https://www.marketstatsville.com/apheresis-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potential markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com